Publication | Closed Access

Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer

Neck CancerMedicinePathologyCancer BiologyHead And Neck CancerAnti-cancer AgentNrf2 InhibitionTumor SuppressorGpx4 Inhibitor-induced FerroptosisPharmacologyTreatment ResistanceCancer ResearchOxidative Stress